Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05747794
Title Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy (AIPAC-003)
Acronym AIPAC-003
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Immutep S.A.S.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | BEL


No variant requirements are available.